Trudeau Government Signals It Will Soon Announce Pharmacare Plan
(Bloomberg) -- Prime Minister Justin Trudeau's government is signaling it could soon announce funding for a pharmacare program, as it looks to help reduce the billions paid out-of-pocket for prescription drugs.
Health Minister Ginette Petitpas Taylor and Finance Minister Bill Morneau spoke Wednesday in Toronto after a government pharmacare advisory council delivered an interim report on a potential system to subsidize certain drug coverage.
The panel recommended creating the “building blocks” for an actual pharmacare program. While there was no announcement, the ministers left little doubt they plan to unveil some kind of pharmacare program.
“We must complete the dream of medicare by finally finding its missing piece, and that missing piece is pharmacare,” Petitpas Taylor said. “Canadians should not have to choose between paying for prescriptions and putting food on the table.”
Morneau said he would not give any hints of whether the upcoming federal budget, due for release on March 19, would include funding for such a program, but joined Petitpas Taylor in stressing the importance of doing something.
“We know that Canadians expect us to deal with what we see as the unfinished business of the Canadian healthcare system, making sure that all Canadians have access to what we know is a critical part of our healthcare system: pharmacare,” Morneau said.
Morneau has previously said he's looking at something that “doesn't throw out the system we currently have.” Canada's budget watchdog has estimated that Canadians pay about C$3.6 billion ($2.7 billion) out-of-pocket for drugs, with government plans and private insurance covering about C$21 billion in annual costs.
To contact the reporters on this story: Doug Alexander in Toronto at dalexander3@bloomberg.net;Josh Wingrove in Ottawa at jwingrove4@bloomberg.net
To contact the editor responsible for this story: David Scanlan at dscanlan@bloomberg.net
©2019 Bloomberg L.P.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
-
Indians Are Travelling, But Not Every Journey Is A Holiday | The Week In Whys
Pilgrims, patients and working women are the real travellers, and the system hasn't quite caught up with them.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.